Publications

Showing

0

out of

0

results

Enhancing mitophagy as a therapeutic approach for neurodegenerative diseases.

Aman Y, Ryan B, Torsetnes SB, Knapskog AB

December 31, 2019

Randomized trial of daily high-dose vitamin D(3) in patients with RRMS receiving subcutaneous interferon β-1a.

Hupperts R, Smolders J, Vieth R,

December 10, 2019

Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis.

Holmøy T, Fevang B, Olsen DB,

December 7, 2019

Validity of self-reported assessment of Severity of Dependence Scale in Medication-Overuse Headache.

Kristoffersen ES, Benth JŠ, Straand J,

December 5, 2019

Patient and service factors associated with referral and admission to inpatient rehabilitation after the acute phase of stroke in Australia and Norway.

Labberton AS, Barra M, Rønning OM,

November 20, 2019

Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer's disease.

Creese B, Vassos E, Bergh S,

October 21, 2019

Fewer ischemic strokes, despite an ageing population: stroke models from observed incidence in Norway 2010-2015.

Rand K, Dahl FA, Viana J, Rønning OM,

October 15, 2019

Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial.

Larsen CS, Myhr KM, Farbu E,

September 30, 2019

Human Cysteine Cathepsins Degrade Immunoglobulin G In Vitro in a Predictable Manner.

Høglund RA, Torsetnes SB, Lossius A,

September 28, 2019

The impact of C-reactive protein levels on headache frequency in the HUNT study 2006-2008.

Hagen K, Stovner LJ, Nilsen KB,

September 25, 2019